Cardiovascular disease due to novel coronavirus and the search for investigational therapies.

Mousa, Albeir Y; Broce, Mike; Lucas, B Daniel

Mousa, Albeir Y; Broce, Mike; Lucas, B Daniel.

Affiliation

Mousa AY; Department of Surgery, Robert C. Byrd Health Sciences Center/West Virginia University, Charleston, WV. Electronic address: amousa@hsc.wvu.edu.
Broce M; Center for Health Services and Outcomes Research, Charleston Area Medical Center Health Education and Research Institute, Charleston, WV.
Lucas BD; Center for Clinical Sciences Research, Charleston Area Medical Center Health Education and Research Institute, Charleston, WV.

J Vasc Surg ; 73(1): 13-17, 2021 01.

Article in En | MEDLINE | ID: mdl-32425326

Subject(s)

Antiviral Agents/therapeutic use; COVID-19 Drug Treatment; Cardiovascular Diseases/drug therapy; Clinical Trials as Topic; Immunologic Factors/therapeutic use; SARS-CoV-2/drug effects; Antiviral Agents/adverse effects; COVID-19/diagnosis; COVID-19/epidemiology; COVID-19/virology; Cardiovascular Diseases/diagnosis; Cardiovascular Diseases/epidemiology; Cardiovascular Diseases/virology; Host-Pathogen Interactions; Humans; Immunologic Factors/adverse effects; Registries; Research Design; Retrospective Studies; SARS-CoV-2/pathogenicity; Treatment Outcome

Key words

COVID-19; Clinical trials; Coronavirus; SARS-CoV-2; Therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Cardiovascular Diseases / Clinical Trials as Topic / SARS-CoV-2 / COVID-19 Drug Treatment / Immunologic Factors Type of study: Diagnostic_studies / Guideline / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Vasc Surg Journal subject: ANGIOLOGIA Year: 2021 Type: Article

Fulltext

XML

PubMed Links

Search on Google